Esophageal Carcinoma — Trials

Esophageal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

807 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 307
Recruiting: 179
Ph III recruiting: 26
Growth YoY: +33.8%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (62)

clinicaltrialsPublishedShowing 401–430 of 430 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02325986	Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer	unknown	Phase 2	46	Sun Yat-sen UniversityOTHER	1	Nov 20, 2015	clinicaltrials
NCT01932580	Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma	completed	Phase 2	10	McGill UniversityOTHER	1	Oct 27, 2015	clinicaltrials